DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials-Reference-Cited by-同舟云学术

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

Published:2011-12 Issue:12 Volume:11 Page:916-924
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Ledgerwood Julie E,Wei Chih-Jen,Hu Zonghui,Gordon Ingelise J,Enama Mary E,Hendel Cynthia S,McTamney Patrick M,Pearce Melissa B,Yassine Hadi M,Boyington Jeffrey C,Bailer Robert,Tumpey Terrence M,Koup Richard A,Mascola John R,Nabel Gary J,Graham Barney S

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference37 articles.

1. Influenza (seasonal) fact sheet;WHO,2009

2. Vaccines for pandemic influenza;Luke;Emerg Infect Dis,2006

3. Human infection with a triple-reassortant swine influenza A(H1N1) virus containing the hemagglutinin and neuraminidase genes of seasonal influenza virus;Bastien;J Infect Dis,2010

4. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans;Garten;Science,2009

5. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009;Shinde;N Engl J Med,2009

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans;Science Translational Medicine;2023-04-19

2. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults;Science Translational Medicine;2023-04-19

3. Immune Control of Avian Influenza Virus Infection and Its Vaccine Development;Vaccines;2023-03-04

4. A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants;Vaccines;2022-10-02

5. Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity;Clinical Microbiology and Infection;2022-10